ABSTRACT: Atrophy with fatty degeneration is often seen in rotator cuff muscles with torn tendons. PRP has been reported to enhance tissue repair processes after tendon ruptures. However, the effect of PRP on atrophy and fatty degeneration of the muscle is not yet known. The aim of this study is to examine the effect of PRP on degeneration change of rotator cuff muscles in vitro and in vivo. A murine myogenic cell line and a rat rotator cuff tear model were used in this study and PRP was administrated into subacromial space which is widely used in clinical practice. In in vitro study, administration of PRP to C2C12 cells stimulated cell proliferation while inhibited both myogenic and adipogenic differentiation. In in vivo study, administration of PRP suppressed Oil Red-O positive lipid droplet formation. The expression of adipogenic genes was also decreased by PRP administration. In conclusion, PRP promoted proliferation of myoblast cells, while inhibiting adipogenic differentiation of myoblast cells and suppressing fatty degeneration change in rat torn rotator cuff muscles. Further investigations are needed to determine the clinical applicability of the PRP. ß
A rotator cuff tear is a common injury that causes shoulder dysfunction. It has been reported that a massive rotator cuff tear causes atrophy and fatty degeneration of rotator cuff muscles. 1 Once muscle atrophy with fatty degeneration takes place following a rotator cuff tear, it is difficult to recover the quality of the muscle, even after torn tendons are repaired. 2 Re-ruptures occurring after a rotator cuff repair are often related to these degenerative changes. 3 Therefore, atrophy with fatty degeneration of rotator cuff muscles is an important prognostic factor in the functional results after surgical repair of the rotator cuff, 4 and prevention of fatty degeneration of muscle is clinically important. Several types of cells isolated from skeletal muscle have been reported to have adipogenic differentiation potential such as satellite cells, 5 side population cells, 6 and mesenchymal stem cells (MSCs). 7 Though it is still unclear whether these cells are responsible for the fatty degeneration of rotator cuff muscles with torn tendons, controlling the differentiation of muscle satellite cells could be one of the key factors in the treatment of rotator cuff tears.
Platelet-rich plasma (PRP) is an autologous concentration of platelets that contains many growth factors. The main growth factors contained in these granules are platelet-derived growth factor (PDGF), transforming growth factor b (TGF-b), fibroblastic growth factor (FGF), vascular endothelial growth factor (VEGF), insulin-like growth factor (IGF), and epidermal growth factor (EGF). 8 Due to its autologous nature, PRP is considered to be safe and free of transmissible diseases and is acceptable for clinical use. Recently, PRP has received increased interest within musculoskeletal research and has been widely applied clinically to stimulate tissue healing. 9 Some studies have shown that injecting PRP into the subacromial space has beneficial effects on tendon-to-bone healing. 10, 11 On the other hand, Ruiz-Moneo et al. have reported that there was no significant difference in the shoulderspecific outcomes between patients treated with PRP and those treated without PRP. 12 Bergeson et al. reported that the rate of rotator cuff retear was significantly higher in the group treated with PRP. 13 These studies have focused on tendon-to-bone healing after PRP injection; however, degenerative changes in muscle after PRP injection have not been well studied.
The aim of this study is to examine the effect of PRP on myogenesis and adipogenesis in C2C12, a satellite cell-derived cell line in vitro model, 14 and on atrophy and fatty degeneration of rotator cuff muscles in a rat rotator cuff tear model.
MATERIALS AND METHODS

In Vitro Experiments
PRP Preparations
Four healthy male volunteers aged 29-33 participated in this study. PRP was prepared according to the double-spinning method previously described. 15 A fixed volume (108 ml) of whole blood was retrieved, and 12 ml of 3.13% sodium citrate (Sekisui Medical, Tokyo, Japan) was immediately added to the blood collection as an anticoagulant. The whole blood was initially centrifuged at 2,400 rotations per minute (rpm) for 10 min to separate plasma from the red cell fraction. A second centrifugation cycle at 3,600 rpm for 15 min was performed to separate PRP from platelet-poor plasma (PPP). The two cycles yielded 10 ml of PRP preparation. The PRP was activated with a deep-freezing method by freezing it at À80˚C to release growth factors. Subsequently, it was centrifuged at 10,000 rpm for 10 min, and the supernatant was stored at À80˚C until used. 15 Platelet counts were performed with a hematology autoanalyzer Sysmex XE-2100 (Sysmex, Kobe, Japan). The donors' platelet counts in venous blood were 2.3 Â 10 5 to 2.8 Â 10 5 platelets/ml. The concentrated platelet counts were 7.2 Â 10 5 to 9.4 Â 10 5 platelets/ml, representing an increase of 306-403% over the baseline venous count.
Cell Culture A murine myogenic cell line, C2C12 was obtained from RIKEN Cell Bank (Tsukuba, Japan). The cells were maintained in a regular medium consisting of Dulbecco's Modified Eagle's Medium (DMEM) (Sigma-Aldrich, St. Louis, MO) and supplemented with 10% fetal bovine serum (FBS) (Sigma-Aldrich), and 1% penicillin-streptomycin (PS) (Sigma-Aldrich) in a 5% CO 2 chamber at 37˚C. For myogenesis, DMEM without FBS was used. For adipogenesis, StemMACS AdipoDiff Media (Miltenyi Biothech, Auburn, CA) was used. The cells were then seeded on 12-well plates at a concentration of 5.0 Â 10 4 cells per well. After the cells had reached confluence, they were cultured in five different mediums: Regular medium only (control group), myogenic medium only (myogenic group), myogenic medium with 10% PRP (myogenic þ PRP group), adipogenic medium only (adipogenic group), and adipogenic medium with 10% PRP (adipogenic þ PRP group). The medium was changed every 48 h.
Cell Morphology and Immunocytochemistry
After 7 days of exposure to three types of differentiation media (control group, myogenic group, myogenic þ PRP group), cells were fixed in 4% paraformaldehyde (PFA). Cell morphology was observed by phase microscopy to examine the degree of myogenic differentiation. For myotube quantification, immunocytostaining was performed. The primary antibodies included myosin heavy chain (MHC) monoclonal antibody (R&D Systems, Minneapolis, MN) at 10 mg/ml for 3 h at room temperature. Cells were stained using the NorthernLights TM 557-conjugated Anti-Mouse IgG Secondary Antibody (R&D Systems) and counterstained with DAPI (diamidino-phenyl-indole). Digital images of MHC (red) and nuclear (blue) staining were captured from five nonoverlapping microscopic fields per well using the Bio Zero BZ-8000 (Keyence, Osaka, Japan). Myotube size and volume were quantified using selective coloring in Adobe Photoshop (CS6; Adobe Systems, San Jose, CA). 16 Cell Proliferation Assay Cell proliferation was measured by a water-soluble tetrazolium salt (WST) assay using a Cell Counting Kit-8 (Dojindo, Kumamoto, Japan), as previously described. 17 Briefly, we used 96-well plates, and each well was seeded with 2,000 cells and filled with 100 ml of medium. Each 96-well plate was cultured in a CO 2 incubator at 37˚C before the WST assay evaluation. Cells were exposed to three differentiation media (control group, myogenic group, myogenic þ PRP group) for 12 and 24 h. For the WST assay, each well was supplemented with 10 ml of WST for 2 h at 37˚C in a CO 2 incubator before spectrophotometric evaluation. Conversion of WST to formazan was spectrophotometrically measured at 450 nm.
Oil Red-O Staining After 7 days of exposure to three differentiation media (control group, adipogenic group, adipogenic þ PRP group), the cells were stained with Oil Red-O solution (Muto Pure Chemicals, Tokyo, Japan) to identify lipid droplets. Accumulation of lipid droplets was observed by phase contrast microscopy. Specifically, the cells were washed with phosphate-buffered saline (PBS) twice, and fixed with 4% PFA for 20 min. They were then washed with PBS again, and the PBS was replaced with 60% isopropanol. The cells were stained with 60% Oil Red-O solution for 20 min at room temperature. The cultures were then washed with 60% isopropanol once, and with distilled water three times. We quantified the number of lipid droplets in five nonoverlapping microscopic fields per well, in accordance with a previously published method. 18 Real-Time PCR At day 3, total RNA was extracted from the cells using an RNeasy Mini Kit (Qiagen, Valencia, CA). Total RNA was reverse transcribed into single-strand cDNA using a HighCapacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA). Real-time PCR was performed in triplicate on the cDNA with an Applied Biosystems 7900HT Fast Real-time PCR System and SYBR Green regents (Applied Biosystems). Results were normalized to housekeeping gene expression levels and expressed relative to the control (untreated) culture levels using the 2 ÀDDCt method. We used Pax7 and myogenin as myogenic markers, and peroxisome proliferator-activated receptor (PPAR) g and CCAAT/enhancer binding protein (C/EBP) a as adipogenic markers.
The primer sequences were as follows: GAPDH:
In Vivo Animal Experiments
PRP Preparations
Van den Dolder et al. reported that rat compared to human PRP showed lower concentrations of growth factors per platelet. However, both rat and human PRP are rich in growth factors, especially TGF-b1. 19 Therefore, we used PRP from rats in animal experiments. One 3-month-old, male, Sprague-Dawley rat was used to prepare PRP. An 8 ml blood sample was retrieved from a rat, and 2 ml of 3.13% sodium citrate (Sekisui Medical) was immediately added to the blood collection as an anticoagulant. PRP was prepared following the double-spinning method. 20 The blood (10 ml) was initially centrifuged at 1,500 rpm for 10 min to separate plasma from the red cell fraction. A second centrifugation cycle at 3,000 rpm for 10 min was performed to separate PRP from platelet-poor plasma (PPP). The two cycles yielded 1 ml of PRP preparation. The PRP was preserved at À80˚C until needed. Platelet counts were performed with an optical microscope. The donor's platelet counts in whole blood were 4.8 Â 10 8 platelets/ml. The concentrated platelet counts were 1.6 Â 10 9 platelets/ml, representing an increase of 340% over the baseline venous count.
Rat Rotator Cuff Tear Model
Thirteen 3-month-old, male, Sprague-Dawley rats weighing 401 AE 36.8 g were used in this study. Five rats were used for a preliminary experiment to verify whether rotator cuff degeneration changes were observed in this rat rotator cuff tear model. Under general anesthesia, a full-thickness supraspinatus and infraspinatus tears were created in the right shoulder to induce atrophy and fatty degeneration of the PRP EFFECT ON MUSCLES rotator cuff muscles (tear group), as previously described. 21 The left shoulder underwent a control procedure where the wound was closed without any tendon resection (no tear group). Thirty days after the surgery, the rats were sacrificed and the supraspinatus and infraspinatus muscles were harvested. The muscles were weighed and the supraspinatus muscles were prepared for biochemical measurements.
A full-thickness supraspinatus and infraspinatus tears were created in the shoulders (bilaterally) of five rats. After suturing the fascia and skin to prevent leakage from the subacromial space, 50 ml of saline solution was then injected using a 26-gauge needle into the subacromial space of the right shoulder (control group) and the same volume of PRP into the left shoulder (PRP group). Following the surgery, all animals were housed in standard cages with unrestricted food, water, and activity. The animals were monitored according to a standardized protocol. Thirty days after the surgery, the rats were sacrificed by intraperitoneal injection of a fatal amount of pentobarbital and the supraspinatus and infraspinatus muscles were harvested. The supraspinatus muscles were weighed and prepared for biochemical measurements. The infraspinatus muscles were prepared for histologic analysis.
Three rats were used to test the accuracy of the PRP injection method using toluidine blue. A full-thickness supraspinatus and infraspinatus tears were created in the bilateral shoulders. Toluidine blue was injected into the subacromial space after skin closure. The rats were sacrificed soon after the injection. The supraspinatus and infraspinatus muscles were harvested and the supraspinatus muscles were prepared for histologic analysis.
Oil Red-O Staining
Infraspinatus muscles were frozen using isopentane cooled in liquid nitrogen, and stored at À80˚C until needed. According to the report from Itoigawa et al., fatty degeneration was more strongly detected in the distal portion of muscle compared to proximal portion. 22 Therefore, distal halves of the infraspinatus muscles were used for histology. Muscles were cryosectioned at a thickness of 10 mm and fixed with 4% PFA. They were then stained with Oil Red-O and counterstained with hematoxylin.
Real-Time PCR
The supraspinatus muscles were minced and enzymatically dissociated with type II Collagenase (Worthington Biochemical Corporation, Lakewood, NJ) and prepared for RNA isolation. Total RNA was extracted from the muscles using an RNeasy Mini Kit. We used Muscle RING Finger Protein-1 (MuRF-1) and atrogin-1 as markers of acute muscle atrophy, PPARg and C/EBPa as adipogenic markers.
The primer sequences were as follows: GAPDH: 
Statistical Analysis
Data were presented as means AE standard deviation (SD) of independent experiments. These analyses were performed with EZR (Saitama Medical Center, Jichi Medical University, Saitama, Japan), which is a graphical user interface for R (The R Foundation for Statistical Computing, Vienna, Austria). 23 Total cell proliferation for each group was expressed as the n-fold difference from the control group. For a comparison of the three groups, a one-way ANOVA followed by a Tukey-Kramer test was performed. For two groups, Welch's t-test was performed. A value of p < 0.05 was considered significant. An asterisk indicates statistically significant differences.
RESULTS
In Vitro Experiments
Cell Morphology and Immunocytochemistry C2C12 showed a spindle-shaped phenotype partly differentiated into myotubes in the control group (Fig. 1A) . There was more extensive myotube formation in the myogenic group compared to the control group (Fig. 1B) . The size and volume of the myotubes were suppressed in the myogenic þ PRP group (Fig. 1C) . Immunocytochemistry for MHC showed an enhancement of myotube formation in the myogenic group (Fig. 1D) . Inhibition of myotube formation was seen in the myogenic þ PRP group (Fig. 1E) . The average area of myotubes in the myogenic group (74,400 AE 9,270 mm 2 ) was significantly decreased in the myogenic þ PRP group (14,200 AE 6,110 mm 2 ) (p < 0.001) (Fig. 1F) .
Cell Proliferation Assay
At 12 h, cell proliferation in the myogenic group and the myogenic þ PRP group were significantly lower than in the control group (p < 0.001, p < 0.001). There was no significant difference between the myogenic group and the myogenic þ PRP group (p ¼ 0.32). At 24 h, cell proliferation in the myogenic þ PRP group was significantly greater than that in the myogenic group (p < 0.001) ( Fig. 2A and B) .
Oil Red-O Staining At day 7, C2C12 myoblast cells in the control group showed no staining with Oil Red-O (Fig. 3A) . Cells cultured in the adipogenic medium showed positive staining of Oil Red-O (Fig. 3B) . The number of lipid droplets from the five non-overlapping microscopic fields in the adipogenic þ PRP group (24.0 AE 3.4) was significantly less than the adipogenic group (56.6 AE 9.8) (p < 0.001) (Fig. 3C and D) .
Real-Time PCR
Pax7 and myogenin gene expression in the myogenic group were significantly increased compared to the control group (p < 0.001, p < 0.001). The expressions of these myogenic markers were significantly suppressed in the myogenic þ PRP group compared to the myogenic group (p < 0.001, p < 0.001) (Fig. 4A and B) . PPARg and C/EBPa gene expression in the adipogenic group were significantly increased compared to the control group (p ¼ 0.019, p < 0.001). The expressions of these adipogenic markers were significantly suppressed in the adipogenic þ PRP group compared to the adipogenic group (p ¼ 0.011, p < 0.001) (Fig. 4C and D) .
In Vivo Animal Experiments Rat Rotator Cuff Tear Model
The weight ratio of supraspinatus and infraspinatus muscles in the tear group to those in the no tear group were 76 AE 9% and 73 AE 9%. There were significant differences (p < 0.001, p ¼ 0.001) (Fig. 5A-D) . In regard to genes associated with muscle atrophy, there was a significant increase in MuRF-1 (p ¼ 0.015), but no change in atrogin-1 (p ¼ 0.054) in the tear group compared to the no tear group (Fig. 5E and F) . PPARg and C/EBPa, genes associated with fatty degeneration, were significantly increased in the tear group compared to the no tear group (p ¼ 0.027, p ¼ 0.041) (Fig. 5G and  H) . Regarding the method of injection, subacromial injection resulted in infiltration of toluidine blue into the distal halves of the supraspinatus and infraspinatus muscles (Fig. 6A and B) . Histological examination showed that toluidine blue penetrated into the muscle fibers through epimysium ( Fig. 6C and D) .
The tendon-to-bone transition of the rotator cuff were filled with scar tissue in both control and PRP groups ( Fig. 7A and B) . No macroscopic difference was observed between the muscles of control and PRP groups (Fig. 7C-F) . The weight ratio of infraspinatus muscles in the PRP group to that in the control group was 104 AE 11%. There was no significant difference (p ¼ 0.36).
Oil Red-O Staining
Oil Red-O positive lipid droplets were observed around intramuscular tendons both in the control group and in the PRP group. On the other hand, the number of lipid droplets observed at 50 mm away from the intramuscular tendons was significantly decreased in the PRP group (7.0 AE 0.7) compared to the control group (18.8 AE 4.9) (p ¼ 0.006), as measured from the five non-overlapping microscopic fields (Fig. 8A-C) . . C2C12 showed a spindle-shaped phenotype partly differentiated into myotubes in the control group (A). There was more extensive myotube formation in the myogenic group compared to the control group (B). The size and volume of the myotubes were suppressed by PRP administration (C). Immunocytochemistry (ICC) for MHC showed a similar tendency (D and E). The average area from five non-overlapping microscopic fields in the myogenic group was significantly decreased in the myogenic þ PRP group (F). 
PRP EFFECT ON MUSCLES
Real-Time PCR There was no significant difference in the expression of MuRF-1 and atrogin-1 between the control group and the PRP group (Fig. 9A and B) 
Transcripts associated with fatty degeneration were significantly suppressed in PRP group compared to the control group. PPARg gene expression was suppressed to 43% in the PRP group compared to the control group (p ¼ 0.007) (Fig. 9C) . C/EBPa gene expression was also suppressed to 22% in the PRP group compared to the control group (p ¼ 0.001) (Fig. 9D) .
DISCUSSION
The proliferation and differentiation of satellite cells are necessary for maintenance of muscle mass. 24 The activation of satellite cells following muscle injury results in the expansion of the myogenic cell pool and leads to the initiation of the myogenic program. This program, orchestrated by key transcription factors, dictates the balance between proliferation and differentiation and drives the functional transformation from individual proliferating myogenic cells to a syncytial contractile myofiber. 25 The proliferation of satellite cells is an essential step in the repair of damaged tissue because the increase in these cell numbers ensures an adequate repopulation of the tissue.
26
Satellite cell numbers decline with age, and such depletion of satellite cells may reduce the efficiency of routine repair following subtle myofiber injuries. 27 Most growth factors contained in PRP stimulate the proliferation of satellite cells and inhibit their differentiation and fusion, except for IGFs. 28 Among them, TGF-b is a potent inhibitor of myoblast differentiation 29 and a key factor in the development of fibrosis in skeletal muscle. 30 Some researchers have raised concerns that PRP treatment may induce a fibrotic healing response in muscle tissues. 9 However, Terada et al. reported that PRP could decrease fibrosis development via an enhancement of angiogenesis resulting from increased levels of VEGF. 31 Dimauro et al. also reported that PRP was beneficial for muscle Figure 5 . Rat Rotator Cuff Tear Model. Sprague-Dawley rats were used in this study. A full-thickness supraspinatus and infraspinatus tears were created in the right shoulder in order to cause atrophy and fatty degeneration of the rotator cuff muscles (tear group), and the left shoulder underwent a control procedure where the wound was closed without any tendon resection (no tear group). Thirty days after the operation, the rats were sacrificed and the supraspinatus and infraspinatus muscles were harvested (A and B). The weight ratio of supraspinatus and infraspinatus muscles in the tear group to those of no tear group were significantly decreased (C and D). In regard to genes associated with muscle atrophy, there was a significant increase in MuRF-1, but no change in atrogin-1 in the tear group compared to the no tear group (E and F). PPARg and C/EBPa gene expression were significantly increased in the tear group compared to the no tear group (G and H). Figure 6 . We previously tested the subacromial injection technique using the same amount of toluidine blue. Subacromial injection resulted in infiltration of toluidine blue into the distal halves of the supraspinatus and infraspinatus muscles (A and B). Histological examination showed that toluidine blue penetrated into the muscle fibers through epimysium (C and D). E shows the supraspinatus muscle which was not stained with toluidine blue.
PRP EFFECT ON MUSCLES
regeneration. The expression of IGF1 was upregulated in the skeletal muscle of rats treated with PRP in their study. 32 The effect of PRP might be due to the effect of IGFs contained in PRP, which promote myogenic satellite cell proliferation and fusion. 33 We found that administration of PRP inhibited myogenic differentiation of myoblast cells. Expression of Pax7 and myogenin were mutually exclusive and overexpression of Pax7 normally stopped cells from cycling and prevented differentiation. 34 In our study, both Pax7 and myogenin gene expression were upregulated during myogenesis, which was contradictory to previous reports. The report using C2C12 showed that Pax7 gene expression was low during the early stages of differentiation.
14 Both Pax7 and myogenin gene expression increased following differentiation 35 and Figure 7 . A full-thickness supraspinatus and infraspinatus tears were created in bilateral shoulders of rats. Saline solution was injected into the subacromial space of the right shoulder (control group) and the same volume of PRP into the left shoulder (PRP group). Thirty days after the operation, the rats were sacrificed and the supraspinatus and infraspinatus muscles were harvested (A and B). Supraspinatus muscles were weighed and prepared for biochemical measurements (C and D). Infraspinatus muscles were prepared for histologic analysis (E and F). The distal halves of the infraspinatus muscles were used (encircled in the figure). myogenin gene expression reached a maximum 3 days after differentiation in C2C12 cells. 36 Therefore, we think that discrepancy form the previous report was due to different assay period with different control. Both Pax7 and myogenin gene expression were decreased by PRP administration because PRP suppressed the differentiation of C2C12 cells. In the cell proliferation assay, PRP accelerated the proliferation of the myoblast cells that are essential for the repair of damaged tissue. This result indicate that PRP could be one effective tool for older populations whose satellite cells are depleted.
Our experiment showed that muscle atrophy occurred 1 month after rotator cuff tenotomy in rat. Gumucio et al. also reported that 30 days after inducing a tear, a reduction in rotator cuff muscles occurred in a rat model. 21 MuRF-1 and atrogin-1 are the major E3 ubiquitin ligases in skeletal muscle and are associated with muscle atrophy. In previous expreriment, MuRF-1 expression from the torn supraspinatus tendon was upregulated, while there was no change in atrogin-1 expression. 21 In our study, MuRF-1 expression significantly increased by creating a rotator cuff tear. Atrogin-1 expression also increased by creating a rotator cuff tear, though the difference was not statistically significant. The administration of PRP did not affect the weight of the supraspinatus muscles and gene expressions associated with muscle atrophy. Therefore, the results of our experiment showed PRP did not induce myogenic activity or prevent muscle atrophy in this model.
For adipogenesis, the effect of PRP varies according to different reports. The addition of PRP greatly amplifies (up to eight times) the insulin-induced adipogenic differentiation of human adipose-derived stem cells (ASCs) through a serine/threonine kinase Akt-dependent mechanism. 37 Hebert et al. reported that the bFGF and EGF contained in PRP could be used as culture supplements to optimize the adipogenic differentiation potential of cryopreserved human ASCs. 38 On the other hand, PRP inhibited the adipogenesis of pre-adipocytes 3T3-L1 and the bone marrow cells of mice. 39 However, there were no previous reports regarding the effect of PRP on the adipogenesis of myoblast cells. We found that PRP inhibited adipogenic differentiation of myoblast cells and suppressed fatty degenerative change of rotator cuff muscles in a rat model. These results can be explained by the effect of TGF-b. It is known that TGF-b contained in PRP is a potent inhibitor of adipocyte differentiation, and the block in differentiation induced by TGF-b is accompanied by decreased mRNA levels for C/EBPa and PPARg, 40, 41 transcription factors which are critical for adipogenesis. 42 Smad6 and Smad7, which transmit or inhibit TGF-b signals, acted as negative regulators of adipogenesis. 43 Therefore, PRP could be a useful treatment tool for the prevention of fatty degenerative change of rotator cuff muscles, and PRP may have the potential to improve clinical outcomes of rotator cuff treatment.
This study has several limitations. First, there is little consensus regarding the production and characterization of PRP and controversy exists in the literature as to the optimal platelet concentration, the use of activators, the presence of white blood cells (WBC), and the timing or number of injections. Deep-freezing is a common method for disrupting cells and releasing intracellular thrombocyte growth factors, 44 and Figure 9 . Real-time PCR (MuRF-1, atrogin-1, PPARg, C/EBPa). Values were normalized to GAPDH expression. There was no change in the expressions of MuRF-1 and atrogin-1 (A and B). PPARg and C/EBPa gene expression were significantly suppressed in the PRP group compared to the control group (C and D).
PRP EFFECT ON MUSCLES activated PRP is more effective than un-activated PRP in vitro. 45 To maintain maximum growth factor bioactivity, we used activated PRP with deep-freezing in the present study. Secondly, we performed subacromial instead of intramuscular injections in this study. Subacromial injections are more commonly used in clinical practice because they cause less pain than intramuscular injections. To confirm injection accuracy, we injected toluidine blue into the subacromial space of rats as a previous report. 46 We ascertained the injection was placed correctly and toluidine blue partially penetrated into the muscle fibers through epimysium. However, the degree of spreading and permeation into the muscle varied between rats. There is room to consider different methods of PRP injection. Thirdly, it is unclear how long the growth factors contained in PRP remained in the injected site and whether single injection of PRP is effective or not. While there are some reports showing single injection of PRP is effective, it is still controversial. Kim et al. reported the sustained delivery of growth factors in PRP using a rat rotator cuff tear model. Although PDGF-AB in the PRP decreased 1 day after PRP injection, it was retained until 21 days. 47 Previous reports show the application of single dose PRP was effective for 3 48 and 8 weeks 11 after injection in a rat rotator cuff tear model. Conversely, Guillodo et al. reported a single dose of PRP was ineffective. 49 Fourth, although C2C12 myoblast cells express proteins necessary for muscle contraction and display the morphology of individual fiber units, there are striking differences between these cells and adult muscle, particularly in their degree of maturation and mode of glucose transport. Therefore, effects in C2C12 myoblast cells do not always translate to adult muscle. 50 In addition, Oil Red-O positive lipid droplets formation associated with adipogenic gene expression was observed in in vivo and vitro. However, we did not assess these cell phenotypes as adipocytes in this study.
In conclusion, PRP promoted proliferation of myoblast cells, while inhibiting adipogenic differentiation of myoblast cells and suppressing fatty degeneration change in rat torn rotator cuff muscles. Further investigations are needed to determine the clinical applicability of the PRP.
